Literature DB >> 18182877

[Stages of change in smoking cessation and factors related to re-smoking after coronary artery bypass graft surgery].

Seung-Hee Choi1, Kyung Ja Song, Smi Choi-Kwon.   

Abstract

PURPOSE: The purpose of this study was to investigate the stages of change in smoking cessation after a Coronary Artery Bypass Graft(CABG) and to identify the related factors.
METHODS: The subjects (n=157) were patients who underwent a CABG in a university hospital from March 1998 to October 2005 and were smokers before the CABG. Data was collected via chart review and a telephone interview, and analyzed with descriptive statistics, chi(2) test, one-way ANOVA, and Kruskal-Wallis procedure by the SPSS/PC win 12.0 program.
RESULTS: The subjects smoked for an average of 34 years (21 cigarettes per day) before surgery. Eleven percent of the subjects were in pre-contemplation, 6.4% in contemplation, 13.5% in preparation, 4.5% in action, and 64.5% in the maintenance stage. Nicotine dependence and self-efficacy were different among the groups with different stages of change in smoking cessation. Nicotine dependence was the lowest (p=0.00) and self-efficacy was the highest (p=0.00) in the maintenance stage. The number of subjects in pre-contemplation and contemplation significantly increased 6 years after surgery (p=0.05).
CONCLUSIONS: To implement effective smoking cessation interventions for CABG patients, the intervention should be developed to accommodate individual readiness for smoking cessation, especially so for those who had a CABG more than 6 years previously.

Entities:  

Mesh:

Year:  2007        PMID: 18182877     DOI: 10.4040/jkan.2007.37.7.1159

Source DB:  PubMed          Journal:  Taehan Kanho Hakhoe Chi        ISSN: 1598-2874


  1 in total

1.  Utilizing a health-promotion model to predict self-care adherence in patients undergoing coronary angioplasty in Bushehr, Iran.

Authors:  Azime Khodaminasab; Mahnoush Reisi; Hakime Vahedparast; Rahim Tahmasebi; Homamodin Javadzade
Journal:  Patient Prefer Adherence       Date:  2019-04-05       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.